Stereotaxis Inc (STXS) Narxning foydaga nisbati

Stereotaxis Inc (STXS) korporativ emblemasi va logotipi

Stereotaxis, Inc. (STXS) kardiologiya uchun robototexnika tizimlarini ishlab chiqadi, biroq qimmat tizimlarning sekin joriy etilishi va an'anaviy davolash usullari bilan raqobat to'siqlarni yuzaga keltirmoqda. Ushbu grafik aktivning qiymatini -3.90 metriki orqali aks ettiradi va u kuchli texnik salohiyat klinikalarning budjet cheklovlari tufayli moslashuvchan lizingni talab qiladigan holatning ko'rsatkichi bo'lib xizmat qiladi. Shu bilan birga, robototexnika aniqligi isroflarni kamaytiradi, bu esa zavod modernizatsiyasi bilan birgalikda ekologik ta'sirni yaxshilaydi.

Stereotaxis Corporation (STXS) Narx-foyda koeffitsiyenti: 04.07.2022 - 12.11.2026 davri uchun

Stereotaxis Corp (STXS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning umumiy tahlili:stereotaxis.com - STXS
stereotaxis.com original mahsuloti

Fundamental aktivlarni saralash biznesning daromad keltirish qobiliyatiga nisbatan bozor qiymatini baholashdan boshlanadi. Stereotaxis, Inc. (STXS) kompaniyasining P/E koeffitsiyenti foydaning bir birligi uchun xarajatni aks ettiradi, bu esa aksiyalar haddan tashqari qimmat baholanganmi yoki o'sish potentsialiga egami ekanligini aniqlash imkonini beradi. Ushbu ko'rsatkichning dinamikasi Stereotaxis, Inc. (STXS) uchun texnologik siklning joriy bosqichidan dalolat beradi. Bu yerda investitsiya jozibadorligi bevosita noyob robotlashtirilgan magnit navigatsiya tizimlarini klinikalarning global tarmog'ida joriy etishni kengaytirishga bog'liq.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori bostonscientific.com|Narxning foydaga nisbati Edwards Lifesciences Corporation (EW)|Narxning foydaga nisbati RMD (ResMed Inc)|P/E multiplikatori PODD (OmniPod)|Biznesning o‘zini qoplash muddati Zimmer Biomet (ZBH)|COO: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E multiplikatori|Narx-foyda multiplikatori AORT (Artivion Corp)|Narx-foyda koeffitsiyenti ENOV (Enovis Corporation)|IART (integralife.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Establishment Labs Holdings Inc. ESTA|BBNX - Narx-foyda koeffitsiyenti|Iradimed - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Embecta Health|TNDM: P/E multiplikatori|Narx-foyda multiplikatori AXGN|SIBN (SI-BONE) - P/E multiplikatori|Orthofix Medical (OFIX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori BVS|Narx-foyda koeffitsiyenti orthopediatrics.com KIDS|P/E multiplikatori TMCI (Treace Medical Concepts)|P/E multiplikatori blade.com SRTA|CARL - Narxning foydaga nisbati|RXST: Narxning foydaga nisbati|CLPT (clearpointneuro.com) - Narx-foyda koeffitsiyenti|Neuronetics, Inc - Kompaniya qiymatining sof foydaga nisbati|SGHT (Sight Sciences, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati orchestrabiomed.com OBIO|Narxning foydaga nisbati Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Jin Medical - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani Medical Inc VANI|Xtant Medical Inc - P/E multiplikatori|Biznesning o‘zini qoplash muddati n1mtc.com NMTC|modular-medical.com (MODD) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati MYO (Myomo Inc.)|Narxning foydaga nisbati Envoy Medical, Inc|Narx-foyda koeffitsiyenti Vivos Therapeutics Inc (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|INVO Fertility Corp - Bozor narxining sof foydaga nisbati|Bone Biologics (BBLG) - Narxning foydaga nisbati|AXNX - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti BIOL|DYNT (Dynatronics Corp.) - Bozor narxining sof foydaga nisbati|P/E multiplikatori FNA|INVO - Kapitalizatsiyaning foydaga nisbati